Definium Therapeutics, Inc. DFTX
NASDAQ · United States · Health Technology
$38.17+0.11 (+0.29%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -1.44 | -0.54 | -166.2% | $0 | — | +3.9%$44.39→$46.14 |
| Q1 2026 | 2026-05-07 | -0.71 | -0.49 | -44.9% | — | — | -5.8%$23.42→$22.05 |
| Q4 2025 | 2026-02-26 | -0.50 | -0.49 | -2.0% | — | — | -1.0%$17.62→$17.45 |
| Q3 2025 | 2025-11-06 | -0.78 | -0.50 | -56.0% | — | — | +1.5%$11.53→$11.70 |
| Q2 2025 | 2025-07-31 | -0.50 | -0.36 | -38.9% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.35 | -0.37 | +5.4% | — | — | — |
| Q4 2024 | 2025-03-06 | -0.41 | -0.28 | -46.4% | — | — | — |
| Q3 2024 | 2024-11-07 | -0.18 | -0.26 | +30.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.